Scholar: Deepak Nagrath

Deepak Nagrath

Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)

Read More

Exploiting metabolic vulnerabilities after anti-VEGF antibody therapy in ovarian cancer

  • Deanna Glassman, Mark S Kim, Meredith Spradlin, …, Livia S Eberlin, Deepak Nagrath, Anil K Sood
  • None, 10.1016/j.isci.2023.106020
Read More

Metabolic collateral lethal target identification reveals MTHFD2 paralogue dependency in ovarian cancer

Read More

Radiotherapy-induced metabolic hallmarks in the tumor microenvironment

  • Anjali Mittal, Minal Nenwani, Itisam Sarangi, Abhinav Achreja, Theodore S Lawrence, Deepak Nagrath
  • Trends Cancer, 10.1016/j.trecan.2022.05.005
Read More